Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

T.J. de Villiers, A.A. Chines, S. Palacios, P.T.A.M. Lips, A.Z. Sawicki, A.B. Levine, C. Codreanu, N. Kelepouris, J.P. Brown

Research output: Contribution to journalArticleAcademicpeer-review

53 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)567-576
JournalOsteoporosis International
Volume22
Issue number2
DOIs
Publication statusPublished - 2011

Cite this